Under The Influence: Prediction Markets Are Harnessing Modern Joe Camels
Brant James, Ingame
Lomedico et al. v. American Behavioral Research Institute LLC, d/b/a Relaxium
22-cv-6097, S.D.N.Y.
(July 2022)
Relaxium
Misleadingly marketing that the supplement is a “clinically proven” sleep aid when the only scientific study conducted on the product was inadequate and sponsored by Relaxium
Falsely advertising that the supplement was developed by a “sleep expert” when he has no experience or background in treating sleep disorders
Brant James, Ingame
Company becomes the latest to leave the industry.
The FTC’s Negative Option Rule do-over – and what’s at stake.
Be wary of questionable and deceptive claims in origin stories.
Mounting lawsuits accuse Meta of breaking privacy promises.